Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



TROP2 and SOX-10 expression in the differential diagnosis of bladder tumors

Ismail Harmankaya, Nevzat Serdar Ugras, Sumeyye Nur Tataroglu.




Abstract
Cited by 0 Articles

Aim: TROP2 is a member of the calcium signal converting gene family, which is highly expressed in various cancers. SOX10 is the nuclear transcription factor associated with the formation and development of various cancers. We investigated the importance of TROP2 and SOX10 in the differential diagnosis of tumoral lesions of the bladder.
Materials and Methods: TROP2 and SOX10 expressions were evaluated by immunohistochemical method in 150 tumoral and 20 non-tumoral bladder tissues.
Results: Strong staining with TROP2 was frequently seen in cases of papillary urothelial neoplasm with low malignant potential. There was no significant difference in the intensity of staining between the nontumoral group and the carcinoma groups, and between noninvasive carcinomas and invasive carcinomas.
Conclusion: Although strong staining with TROP2 indicates tumoral development, widespread staining does not show this. Expression loss in TROP2 is observed in muscle invasive carcinomas. Strong and widespread (≥ 50%) TROP2 staining indicates papillary urothelial neoplasm with low malignant potential. Evaluation of this finding together with histomorphological findings may help to make an accurate diagnosis.

Key words: Bladder cancer; immunohistochemistry; SOX10; TROP2






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.